StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories u.S. FDA MAUDE Adverse Event MDR Reports — Abbott Total

U.S. FDA openFDA MAUDE Post-Market Surveillance API

QuarterlyAnnualMonthly
Latest, Sep 2026
121,122
Period ended Sep 30, 2026
Change on a year earlier
+1,460.6%
7,761 in Sep 2025
History
153 months
Since Jan 2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. FDA MAUDE Adverse Event MDR Reports — Abbott TotalYear on yearSource
Sep 2026Sep 30, 2026121,122+1,460.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Aug 2026Aug 31, 2026136,060+1,546.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jul 2026Jul 31, 202638,749+317.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jun 2026Jun 30, 202651,852+539.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
May 2026May 31, 202648,294+543.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Apr 2026Apr 30, 202643,720+462.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Mar 2026Mar 31, 202612,574+74.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Feb 2026Feb 28, 20267,229+6.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jan 2026Jan 31, 20269,597+37.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Dec 2025Dec 31, 20259,552+31.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Nov 2025Nov 30, 20256,672-5.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Oct 2025Oct 31, 20257,460-7.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Sep 2025Sep 30, 20257,761-0.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Aug 2025Aug 31, 20258,265-8.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jul 2025Jul 31, 20259,272+13.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jun 2025Jun 30, 20258,113+14.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Breakdown

What makes up u.s. fda maude adverse event mdr reports — abbott total

Cite this data

StockData. (2026). Abbott Laboratories U.S. FDA MAUDE Adverse Event MDR Reports — Abbott Total, monthly Jan 2014–Sep 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-maude-tot

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.